HealthQuill FDA
Drugs Medical Pharma

FDA approves Santhera’s Agamree for Duchenne muscular dystrophy

HQ team October 31, 2023: The US Food and Drug Administration (FDA) has given the green light to Santhera Pharmaceuticals’ drug, Agamree (vamorolone),.

Read More
The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due to the potential risk of infections.
Drugs Health Pharma

FDA warns against use of certain OTC eye drop products

HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.

Read More
The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.
Drugs Health Pharma

BioMarin’s achondroplasia drug gets nod for children of all ages

HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.

Read More
The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years and 25 years.
Drugs Health Pharma

Pfizer’s vaccine for meningococcal disease gets FDA approval

HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.

Read More
Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative pain treatment drug.
Drugs Health Pharma

Belgium’s Hyloris gets nod for post-operative pain reduction drug

HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.

Read More
Eli Lilly and Company announced its experimental drug for treating severe Crohn's disease met secondary targets in efficacy and safety.
Drugs Health Pharma

Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals

HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.

Read More
Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people with type 2 diabetes and chronic kidney disease after the interim results met certain pre-specified” criteria for efficacy.
Drugs Health Pharma

Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals

HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.

Read More
Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of adverse events, and are not approved by the FDA, the regulator warned.
Drugs Health Pharma

FDA warns patients against use of ketamine for psychiatric disorders

 HQ Team October 10, 2023: Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of.

Read More
Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.
Drugs Health Pharma

Users of diabetic drugs for weight loss at risk of stomach paralysis

HQ Team October 7, 2023: Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction,.

Read More
Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA said it was “unsatisfied” with the status of a recall.
Health Medical Pharma

US drug regulator ‘unsatisfied’ by Philips’s progress on ventilator recall

HQ Team October 6, 2023: Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA.

Read More